VGI MEDICAL, LLC


Associated tags: 3D, Sacrum, Medical device, University of Toledo, Ilium, Patient, Pain, VGI, University, Quality of life, Rotation, SI, US FDA, US, NASS, 3D printing, Titanium

Locations: FLORIDA

VGI Medical, LLC Announces The Launch of the new SiJoin® Transfixing Triangular Trabecular Titanium (T4) Implant System, for Sacroiliac Joint Transfixation, at NASS 2023

Retrieved on: 
Wednesday, October 18, 2023
3D, Sacrum, US, US FDA, SI, Rotation, Multimedia, Quality of life, University, VGI, Pain, Patient, Ilium, University of Toledo, NASS, Medical device, 3D printing

LARGO, Fla., Oct. 18, 2023 /PRNewswire-PRWeb/ -- VGI Medical, LLC launches the new US FDA 510(k) cleared SiJoin® Transfixing Triangular Trabecular Titanium (T4) Implant System. The transfixing SiJoin® T4 Implant is made from Ti-6AI-4V ELI titanium alloy using an additive manufacturing process, where the porous trabecular construction is engineered to mimic cancellous bone structure. The implant has an engineered lattice design to achieve 500-700 mm pores, and has undergone post processing to create micro and nano surface structures facilitating the proliferation of osteoblast adhesion and bony in-growth. The SiJoin® T4 Implant is engineered with a dual geometric shape designed to be simultaneously positioned within the illium and sacrum, through the respective cortical wall, providing high surface area contact for fixation. The implant is held against rotation via the stabilizer fins positioned between the opposing illium and sacrum surfaces, and the non-circular cross-section of the main body. The patented novel design of the SiJoin® T4 Implant fixes the sacrum and ilium relative to one another, maintaining the anatomical spacing of the SI joint, providing mechanical support by transfixing the SI joint while biologic fusion occurs.

Key Points: 
  • VGI Medical, LLC announces the launch of the new SiJoin® Transfixing Triangular Trabecular Titanium (T4) Implant System.
  • VGI's superior engineering and testing has allowed them to design a titanium alloy implant for use in alleviating sacroiliac joint pain and create a simplified process for the surgeon.
  • LARGO, Fla., Oct. 18, 2023 /PRNewswire-PRWeb/ -- VGI Medical, LLC launches the new US FDA 510(k) cleared SiJoin® Transfixing Triangular Trabecular Titanium (T4) Implant System.
  • The transfixing SiJoin® T4 Implant is made from Ti-6AI-4V ELI titanium alloy using an additive manufacturing process, where the porous trabecular construction is engineered to mimic cancellous bone structure.

VGI Medical, LLC Announces FDA Clearance of the Novel 3D Printed SiJoin® T3 Implant System, for Sacroiliac Joint Transfixation

Retrieved on: 
Tuesday, April 18, 2023
VGI, SI, US FDA, Ilium, Rotation, University of Toledo, 3D, Quality of life, Titanium, Pain, US, Patient, University, Sacrum, Medical device

LARGO, Fla., April 18, 2023 /PRNewswire-PRWeb/ -- VGI Medical, LLC announces the new US FDA 510(k) cleared SiJoin®  Triangular Trabecular Titanium (T3) Implant System. The transfixing SiJoin®  T3 Implant is made from Ti-6AI-4V ELI titanium alloy using an additive manufacturing process, where the trabecular construction is engineered to mimic cancellous bone structure. The SiJoin®  T3 Implant is engineered with a dual geometric shape designed to be implanted within the plane of the SI joint, simultaneously positioned within the cortical walls of the ilium and sacrum, providing high surface area contact for transfixation. The implant is held against rotation via the stabilizer fins positioned between the opposing ilium and sacrum surfaces, and the non-circular cross-section of the main body. The novel design of the SiJoin®  T3 Implant fixes the ilium and sacrum relative to one another, maintaining the anatomical spacing of the SI joint, providing mechanical support by transfixing the SI joint while biologic fusion occurs.

Key Points: 
  • VGI Medical, LLC announces it has received 510(k) clearance from the United States Food and Drug Administration to market the transfixing SiJoin® Triangular Trabecular Titanium (T3) Implant System.
  • LARGO, Fla., April 18, 2023 /PRNewswire-PRWeb/ -- VGI Medical, LLC announces the new US FDA 510(k) cleared SiJoin® Triangular Trabecular Titanium (T3) Implant System.
  • Specialized SiJoin® directional instrumentation deploys the implant into the SI joint, positioned across the joint, within the ilium and sacrum for transfixing of the SI joint.
  • We are excited to provide an advancement of this existing technology by incorporating the benefits of a 3D printed titanium implant–.